Position in IMCR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$26,386,409
-$1,331,450 QoQ
Shares Held
831,068
-9.6% QoQ
Ownership
1.61%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#18
of 136 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in IMCR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $17,555,651,841 across 303 Biotechnology names. IMCR ranks #86 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
2,678,047 | $2,484,611,664 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,529,709 | $953,834,749 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,728,421 | $858,558,562 | |
| 4 | KYMR |
Kymera Therapeutics, Inc.
|
7,112,980 | $815,645,416 | |
| 5 | RPRX |
Royalty Pharma plc
|
11,193,657 | $627,628,347 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
2,969,853 | $447,655,945 | |
| 7 | MRNA |
Moderna, Inc.
|
5,589,560 | $391,436,886 | |
| 8 | SRRK |
Scholar Rock Holding Corp
|
6,794,837 | $373,716,035 |
All Filings in IMCR
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $26,386,409 | 831,068 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $27,717,859 | 919,332 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $33,626,492 | 968,784 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $36,939,290 | 1,016,771 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $31,555,476 | 1,005,592 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $56,015,179 | 1,887,940 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $64,532,135 | 2,187,530 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $67,169,138 | 2,157,698 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $95,999,152 | 2,832,669 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $158,442,960 | 2,437,584 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $201,173,295 | 2,944,574 | Shares | Sole | 2024-02-16 | |
| 2023-09-30 | $130,854,639 | 2,521,284 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $145,308,263 | 2,423,420 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $68,397,273 | 1,383,440 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $76,126,586 | 1,333,916 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $54,617,553 | 1,163,561 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $11,711,571 | 313,899 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $10,264,042 | 343,279 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $13,007,467 | 379,891 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $13,420,303 | 362,026 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $14,343,221 | 367,304 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $16,513,413 | 387,912 | Shares | Sole | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||